Ignite Creation Date:
2024-05-06 @ 3:45 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04745988
Status:
RECRUITING
Last Update Posted:
2022-11-14
First Post:
2021-02-08
Brief Title:
An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib Pembrolizumab and FLOT in the Neoadjuvant Adjuvant Treatment for Patients With Gastric Cancer
Sponsor:
National Cancer Center Hospital East
Organization:
National Cancer Center Hospital East
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Gastric Cancer |
Keywords: